|
1
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liotta LA and Kohn E: The microenvironment
of the tumour-host interface. Nature. 411:375–379. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakagawa H, Liyanarachchi S, Davuluri RV,
Auer H, Martin EW Jr, de la Chapelle A and Frankel WL: Role of
cancer-associated stromal fibroblasts in metastatic colon cancer to
the liver and their expression profiles. Oncogene. 23:7366–7377.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shiga K, Hara M, Nagasaki T, Sato T,
Takahashi H and Takeyama H: Cancer-associated fibroblasts: Their
characteristics and their roles in tumor growth. Cancers (Basel).
7:2443–2458. 2015. View Article : Google Scholar
|
|
5
|
Koliaraki V, Pallangyo CK, Greten FR and
Kollias G: Mesenchymal cells in colon cancer. Gastroenterology.
152:964–979. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Orimo A and Weinberg RA: Heterogeneity of
stromal fibroblasts in tumors. Cancer Biol Ther. 6:618–619. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagasaki T, Hara M, Nakanishi H, Takahashi
H, Sato M and Takeyama H: Interleukin-6 released by colon
cancer-associated fibroblasts is critical for tumour angiogenesis:
Anti-interleukin-6 receptor antibody suppressed angiogenesis and
inhibited tumourstroma interaction. Br J Cancer. 110:469–478. 2014.
View Article : Google Scholar
|
|
8
|
Shen J, Zhai J, You Q, Zhang G, He M, Yao
X and Shen L: Cancer-associated fibroblasts-derived VCAM1 induced
by H. pylori infection facilitates tumor invasion in gastric
cancer. Oncogene. 39:2961–2974. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Neesse A, Michl P, Frese KK, Feig C, Cook
N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM and
Tuveson DA: Stromal biology and therapy in pancreatic cancer. Gut.
60:861–868. 2011. View Article : Google Scholar
|
|
10
|
Comito G, Giannoni E, Segura CP,
Barcellos-de-Souza P, Raspollini MR, Baroni G, Lanciotti M, Serni S
and Chiarugi P: Cancer-associated fibroblasts and M2-polarized
macrophages synergize during prostate carcinoma progression.
Oncogene. 33:2423–2431. 2014. View Article : Google Scholar
|
|
11
|
Cohen N, Shani O, Raz Y, Sharon Y, Hoffman
D, Abramovitz L and Erez N: Fibroblasts drive an immunosuppressive
and growth-promoting microenvironment in breast cancer via
secretion of Chitinase 3-like 1. Oncogene. 36:4457–4468. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hegab AE, Ozaki M, Kameyama N, Gao J,
Kagawa S, Yasuda H, Soejima K, Yin Y, Guzy RD, Nakamura Y, et al:
Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its
cancer-associated fibroblasts. J Pathol. 249:193–205. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kojima Y, Acar A, Eaton EN, Mellody KT,
Scheel C, Ben-Porath I, Onder TT, Wang ZC, Richardson AL, Weinberg
RA and Orimo A: Autocrine TGF-beta and stromal cell-derived
factor-1 (SDF-1) signaling drives the evolution of tumor-promoting
mammary stromal myofibroblasts. Proc Natl Acad Sci USA.
107:20009–20014. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iwano M, Plieth D, Danoff TM, Xue C, Okada
H and Neilson EG: Evidence that fibroblasts derive from epithelium
during tissue fibrosis. J Clin Invest. 110:341–350. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeisberg EM, Potenta S, Xie L, Zeisberg M
and Kalluri R: Discovery of endothelial to mesenchymal transition
as a source for carcinoma-associated fibroblasts. Cancer Res.
67:10123–10128. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mishra PJ, Mishra PJ, Humeniuk R, Medina
DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW and Banerjee D:
Carcinoma associated fibroblast like differentiation of human
mesenchymal stem cells. Cancer Res. 68:4331–4339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Quante M, Tu SP, Tomita H, Gonda T, Wang
SS, Takashi S, Baik GH, Shibata W, Diprete B, Betz KS, et al: Bone
marrow-derived myofibroblasts contribute to the mesenchymal stem
cell niche and promote tumor growth. Cancer Cell. 19:257–272. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jotzu C, Alt E, Welte G, Li J, Hennessy
BT, Devarajan E, Krishnappa S, Pinilla S, Droll L and Song YH:
Adipose tissue derived stem cells differentiate into
carcinoma-associated fibroblast-like cells under the influence of
tumor derived factors. Cell Oncol (Dordr). 34:55–67. 2011.
View Article : Google Scholar
|
|
20
|
Wu MH, Hong HC, Hong TM, Chiang WF, Jin YT
and Chen YL: Targeting Galectin-1 in carcinoma-associated
fibroblasts inhibits oral squamous cell carcinoma metastasis by
downregulating MCP-1/CCL2 expression. Clin Cancer Res.
17:1306–1316. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Tang H, Cai J, Zhang T, Guo J,
Feng D and Wang Z: Ovarian cancer-associated fibroblasts contribute
to epithelial ovarian carcinoma metastasis by promoting
angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer
Lett. 303:47–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei L, Ye H, Li G, Lu Y, Zhou Q, Zheng S,
Lin Q, Liu Y, Li Z and Chen R: Cancer-associated fibroblasts
promote progression and gemcitabine resistance via the SDF-1/SATB-1
pathway in pancreatic cancer. Cell Death Dis. 9:10652018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hara M, Nagasaki T, Shiga K and Takeyama
H: Suppression of Cancer-associated fibroblasts and endothelial
cells by Itraconazole in Bevacizumab-resistant gastrointestinal
cancer. Anticancer Res. 36:169–177. 2016.PubMed/NCBI
|
|
24
|
Itoh G, Chida S, Yanagihara K, Yashiro M,
Aiba N and Tanaka M: Cancer-associated fibroblasts induce cancer
cell apoptosis that regulates invasion mode of tumours. Oncogene.
36:4434–4444. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hakala BE, White C and Recklies AD: Human
cartilage gp-39, a major secretory product of articular
chondrocytes and synovial cells, is a mammalian member of a
chitinase protein family. J Biol Chem. 268:25803–25810. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao T, Su Z, Li Y, Zhang X and You Q:
Chitinase-3 like-protein-1 function and its role in diseases.
Signal Transduct Target Ther. 5:2012020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bara I, Ozier A, Girodet PO, Carvalho G,
Cattiaux J, Begueret H, Thumerel M, Ousova O, Kolbeck R, Coyle AJ,
et al: Role of YKL-40 in bronchial smooth muscle remodeling in
asthma. Am J Respir Crit Care Med. 185:715–722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Berres ML, Papen S, Pauels K, Schmitz P,
Zaldivar MM, Hellerbrand C, Mueller T, Berg T, Weiskirchen R,
Trautwein C, et al: A functional variation in CHI3L1 is associated
with severity of liver fibrosis and YKL-40 serum levels in chronic
hepatitis C infection. J Hepatol. 50:370–376. 2009. View Article : Google Scholar
|
|
29
|
Volck B, Johansen JS, Stoltenberg M,
Garbarsch C, Price PA, Ostergaard M, Ostergaard K, Løvgreen-Nielsen
P, Sonne-Holm S and Lorenzen I: Studies on YKL-40 in knee joints of
patients with rheumatoid arthritis and osteoarthritis. Involvement
of YKL-40 in the joint pathology. Osteoarthritis Cartilage.
9:203–214. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cintin C, Johansen JS, Christensen IJ,
Price PA, Sørensen S and Nielsen HJ: High serum YKL-40 level after
surgery for colorectal carcinoma is related to short survival.
Cancer. 95:267–274. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Francescone RA, Scully S, Faibish M,
Taylor SL, Oh D, Moral L, Yan W, Bentley B and Shao R: Role of
YKL-40 in the angiogenesis, radioresistance, and progression of
glioblastoma. J Biol Chem. 286:15332–15343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shao R, Hamel K, Petersen L, Cao QJ,
Arenas RB, Bigelow C, Bentley B and Yan W: YKL-40, a secreted
glycoprotein, promotes tumor angiogenesis. Oncogene. 28:4456–4468.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kawada M, Seno H, Kanda K, Nakanishi Y,
Akitake R, Komekado H, Kawada K, Sakai Y, Mizoguchi E and Chiba T:
Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis
in colorectal cancer. Oncogene. 31:3111–3123. 2012. View Article : Google Scholar :
|
|
34
|
Riabov V, Gudima A, Wang N, Mickley A,
Orekhov A and Kzhyshkowska J: Role of tumor associated macrophages
in tumor angiogenesis and lymphangiogenesis. Front Physiol.
5:752014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fan JT, Zhou ZY, Luo YL, Luo Q, Chen SB,
Zhao JC and Chen QR: Exosomal lncRNA NEAT1 from cancer-associated
fibroblasts facilitates endometrial cancer progression via
miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway. Neoplasia.
23:692–703. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li A, Dubey S, Varney ML, Dave BJ and
Singh RK: IL-8 directly enhanced endothelial cell survival,
proliferation, and matrix metalloproteinases production and
regulated angiogenesis. J Immunol. 170:3369–3376. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Spengler K, Kryeziu N, Große S, Mosig AS
and Heller R: VEGF triggers transient induction of autophagy in
endothelial cells via AMPKα1. Cells. 9:6872020. View Article : Google Scholar
|
|
38
|
Chen CC, Pekow J, Llado V, Kanneganti M,
Lau CW, Mizoguchi A, Mino-Kenudson M, Bissonnette M and Mizoguchi
E: Chitinase 3-like-1 expression in colonic epithelial cells as a
potentially novel marker for colitis-associated neoplasia. Am J
Pathol. 179:1494–1503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tang H, Sun Y, Shi Z, Huang H, Fang Z,
Chen J, Xiu Q and Li B: YKL-40 induces IL-8 expression from
bronchial epithelium via MAPK (JNK and ERK) and NF-κB pathways,
causing bronchial smooth muscle proliferation and migration. J
Immunol. 190:438–446. 2013. View Article : Google Scholar
|
|
40
|
Maeda Y, Takahashi H, Nakai N, Yanagita T,
Ando N, Okubo T, Saito K, Shiga K, Hirokawa T, Hara M, et al:
Apigenin induces apoptosis by suppressing Bcl-xl and Mcl-1
simultaneously via signal transducer and activator of transcription
3 signaling in colon cancer. Int J Oncol. 52:1661–1673.
2018.PubMed/NCBI
|
|
41
|
Bustin SA: Quantification of mRNA using
real-time reverse transcription PCR (RT-PCR): Trends and problems.
J Mol Endocrinol. 29:23–39. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zarour LR, Anand S, Billingsley KG, Bisson
WH, Cercek A, Clarke MF, Coussens LM, Gast CE, Geltzeiler CB,
Hansen L, et al: Colorectal cancer liver metastasis: Evolving
paradigms and future directions. Cell Mol Gastroenterol Hepatol.
3:163–173. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Melzer C, von der Ohe J, Lehnert H,
Ungefroren H and Hass R: Cancer stem cell niche models and
contribution by mesenchymal stroma/stem cells. Mol Cancer.
16:282017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee CM, He CH, Nour AM, Zhou Y, Ma B, Park
JW, Kim KH, Dela Cruz C, Sharma L, Nasr ML, et al: IL-13Ralpha2
uses TMEM219 in chitinase 3-like-1-induced signalling and effector
responses. Nat Commun. 7:127522016. View Article : Google Scholar
|
|
45
|
He CH, Lee CG, Dela Cruz CS, Lee CM, Zhou
Y, Ahangari F, Ma B, Herzog EL, Rosenberg SA, Li Y, et al:
Chitinase 3-like 1 regulates cellular and tissue responses via
IL-13 receptor α2. Cell Rep. 4:830–841. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
He CH, Lee CG, Ma B, Kamle S, Choi AMK and
Elias JA: N-glycosylation regulates chitinase 3-like-1 and IL-13
ligand binding to IL-13 receptor α2. Am J Respir Cell Mol Biol.
63:386–395. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen Y, Zhang S, Wang Q and Zhang X:
Tumor-recruited M2 macrophages promote gastric and breast cancer
metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol
Oncol. 10:362017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Brat DJ, Bellail AC and Van Meir EG: The
role of interleukin-8 and its receptors in gliomagenesis and
tumoral angiogenesis. Neuro Oncol. 7:122–133. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Beard RE, Abate-Daga D, Rosati SF, Zheng
Z, Wunderlich JR, Rosenberg SA and Morgan RA: Gene expression
profiling using nanostring digital RNA counting to identify
potential target antigens for melanoma immunotherapy. Clin Cancer
Res. 19:4941–4950. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kawakami M, Kawakami K, Kasperbauer JL,
Hinkley LL, Tsukuda M, Strome SE and Puri RK: Interleukin-13
receptor alpha2 chain in human head and neck cancer serves as a
unique diagnostic marker. Clin Cancer Res. 9:6381–6388.
2003.PubMed/NCBI
|
|
51
|
Joshi BH, Plautz GE and Puri RK:
Interleukin-13 receptor alpha chain: A novel tumor-associated
transmembrane protein in primary explants of human malignant
gliomas. Cancer Res. 60:1168–1172. 2000.PubMed/NCBI
|
|
52
|
Barderas R, Bartolomé RA,
Fernandez-Aceñero MJ, Torres S and Casal JI: High expression of
IL-13 receptor α2 in colorectal cancer is associated with invasion,
liver metastasis, and poor prognosis. Cancer Res. 72:2780–2790.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Geng B, Pan J, Zhao T, Ji J, Zhang C, Che
Y, Yang J, Shi H, Li J, Zhou H, et al: Chitinase 3-like 1-CD44
interaction promotes metastasis and epithelial-to-mesenchymal
transition through β-catenin/Erk/Akt signaling in gastric cancer. J
Exp Clin Cancer Res. 37:2082018. View Article : Google Scholar
|
|
54
|
Piawah S and Venook AP: Targeted therapy
for colorectal cancer metastases: A review of current methods of
molecularly targeted therapy and the use of tumor biomarkers in the
treatment of metastatic colorectal cancer. Cancer. 125:4139–4147.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ando N, Hara M, Shiga K, Yanagita T,
Takasu K, Nakai N, Maeda Y, Hirokawa T, Takahashi H, Ishiguro H, et
al: Eicosapentaenoic acid suppresses angiogenesis via reducing
secretion of IL-6 and VEGF from colon cancer-associated
fibroblasts. Oncol Rep. 42:339–349. 2019.PubMed/NCBI
|
|
56
|
Togo S, Polanska UM, Horimoto Y and Orimo
A: Carcinoma-associated fibroblasts are a promising therapeutic
target. Cancers (Basel). 5:149–169. 2013. View Article : Google Scholar
|
|
57
|
Roma-Rodrigues C, Mendes R, Baptista PV
and Fernandes AR: Targeting tumor microenvironment for cancer
therapy. Int J Mol Sci. 20:8402019. View Article : Google Scholar :
|
